A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
NCT01201967 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 183
Last updated 2014-09-25
Summary
For this trial, the investigators propose a prospective trial of a collaborative care program to identify and treat depression, generalized anxiety disorder, and panic disorder among patients admitted to the hospital for an acute cardiac illness (acute coronary syndrome, congestive heart failure, or arrhythmia). Such assessment and treatment for depression/generalized anxiety disorder/panic disorder will begin in the hospital, and ongoing management will continue for six months following discharge.
The investigators hypothesize that this model will lead to increased treatment rates, improved mood, reduced anxiety, and improved medical outcomes in this vulnerable population. If this model is effective, it could be implemented clinically to provide better and more complete care to patients hospitalized with acute cardiac illness, for whom depression and anxiety may be a risk factor for complications and death.
This will be a two-arm, single-blind randomized controlled trial, with one-half of patients randomized to collaborative care and one-half randomized to the control condition (usual care). Psychiatric treatment in the intervention arm will be provided in concert with patients' primary care physicians-with primary care physicians prescribing all medications-within a framework supervised by a psychiatrist.
The investigators will enroll patients who have any (or all) of the three included psychiatric diagnoses to improve the utility of the intervention. The investigators have chosen to enroll patients with several different cardiac diagnoses. This will allow the researchers to include patients with heterogeneous diagnoses and illness severity to determine if our intervention is effective in a broad population of patients with heart disease. The investigators will study an intervention targeting depression, generalized anxiety disorder, and panic disorder: all three disorders are disabling and associated with adverse cardiovascular outcomes, treatments for the conditions are highly similar, the investigators can treat patients who have more than one disorder, and a prior outpatient program successfully simultaneously addressed more than one mental health condition.
The project will involve: (1) screening patients for depression, generalized anxiety disorder, and panic disorder as part of usual clinical care, (2) evaluation of positive-screen patients by a study social work care manager, (3) a multicomponent in-hospital intervention (for collaborative care patients) that involves patient education, specialist-provided treatment recommendations, and a goal of in-hospital treatment initiation, and (4), after discharge, continued phone-based evaluation and care coordination with primary care physicians to provide stepwise treatment in the collaborative care arm. The intervention has been designed to be low-cost, low-burden, and easily generalizable to other settings.
Conditions
- Depression
- Generalized Anxiety Disorder
- Panic Disorder
Interventions
- OTHER
-
Collaborative care
Study care manager provides psychoeducation, therapy, and care coordination between patient, psychiatrist, and primary medical physicians.
- OTHER
-
Usual care
Patient's primary medical physician informed of mental health symptoms/diagnosis
Sponsors & Collaborators
- collaborator OTHER
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Jeff C Huffman, MD · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- United States
Study Locations
More Related Trials
-
Special Investigation Of J Zoloft For Panic Disorder Patients
NCT00605917 ·Status: COMPLETED
-
Treatment of Patients With Anxiety Disorder (0777-022)
NCT00539578 ·Status: COMPLETED ·Phase: PHASE2
-
Experimental Medication For the Treatment of Generalized Anxiety Disorder
NCT00097708 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating How the Brain Processes Different Experiences
NCT06051084 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
NCT07336238 ·Status: RECRUITING ·Phase: PHASE2
-
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
NCT05683223 ·Status: RECRUITING ·Phase: NA
-
Generalized Anxiety and Seroquel
NCT01066143 ·Status: TERMINATED ·Phase: NA
-
The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
NCT00438971 ·Status: COMPLETED ·Phase: PHASE4
-
Telephone-Based Care Management Program for Individuals With Anxiety Disorders
NCT00158327 ·Status: COMPLETED ·Phase: PHASE3
-
Brief Group Psychotherapy for Anxiety and Depression
NCT04489641 ·Status: COMPLETED ·Phase: NA
-
A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder
NCT00677352 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders
NCT00102427 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
NCT00736346 ·Status: UNKNOWN ·Phase: NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
NCT04895995 ·Status: RECRUITING ·Phase: NA
-
The Effects of Treatment With Sertraline for Noncardiac Chest Pain
NCT01114100 ·Status: COMPLETED ·Phase: PHASE4
-
Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial
NCT01296321 ·Status: UNKNOWN ·Phase: NA
-
The Modular Protocol for Mental Health (MPMH)
NCT03143634 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MBCT for Psoriasis Patients With Anxiety and Depression
NCT05010044 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder
NCT04366011 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
NCT00930293 ·Status: COMPLETED ·Phase: NA
-
Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
NCT00182533 ·Status: TERMINATED ·Phase: PHASE4
-
ACT with NMOSD Patients and Caregivers Pilot Study
NCT05840055 ·Status: COMPLETED ·Phase: NA
-
Primary Care Intervention Strategy for Anxiety Disorders
NCT00347269 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of ICBT for Severe Health Anxiety in Clinical Psychiatry.
NCT04921280 ·Status: COMPLETED
-
Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
NCT04174170 ·Status: COMPLETED ·Phase: PHASE3